Literature DB >> 206908

Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.

L C Tang, G C Cotzias.   

Abstract

The effect of several concentrations of morphine on the activity of adenylate cyclase [ATP pyrophosphate-lyase (cyclizing): EC 4.6.1.1.] was measured in homogenates of caudate nuclei of mice. Morphine stimulated the enzyme at 500 micron and inhibited slightly at 5 micron. Morphine stimulation was blocked by naloxone. Depending on its dose, morphine also increased or decreased the stimulating effect of dopamine on the dopamine-sensitive adenylate cyclase activity of caudate homogenate. Like dopamine, morphine'e effect on the adenylate cyclase activity was increased or decreased, respectively, by pretreating the animals with poly(I).poly(C) or with chloramphenicol. Thus, both dopamine and morphine appear to act on the same receptor. This "new" receptor differs from the one described by Snyder et al. and others, who demonstrated only binding affinity and no enzymatic activity. These data indicate that certain functions of the opiates might be mediated through the dopamine-sensitive adenylate cyclase of the caudate nuclei, which are the dopamine receptors in the brain.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206908      PMCID: PMC411510          DOI: 10.1073/pnas.75.3.1546

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  An endogenous morphine-like factor in mammalian brain.

Authors:  G W Pasternak; R Goodman; S H Snyder
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

2.  A peptide-like substance from pituitary that acts like morphine. I. Isolation.

Authors:  H Teschemacher; K E Opheim; B M Cox; A Goldstein
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

3.  Effects of morphine, L-DOPA and tetrabenazine on the lamina V cells of spinal dorsal horn.

Authors:  H Takagi; T Doi; K Kawasaki
Journal:  Life Sci       Date:  1975-07-01       Impact factor: 5.037

4.  A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE.

Authors:  R J WURTMAN; J AXELROD
Journal:  Biochem Pharmacol       Date:  1963-12       Impact factor: 5.858

5.  Concomitant analysis for oxygen uptake and ammonia evolution during the monoamine oxidase reaction.

Authors:  G C COTZIAS; J J GREENOUGH
Journal:  Arch Biochem Biophys       Date:  1958-05       Impact factor: 4.013

6.  Letter: Use of L-dopa to relieve pain from bone metastases.

Authors:  D W Nixon
Journal:  N Engl J Med       Date:  1975-03-20       Impact factor: 91.245

7.  Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system.

Authors:  R Simantov; M J Kuhar; G R Uhl; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

8.  Opposing effects of dopaminergic to cholinergic compounds on a cerebral dopamine-activated adenylate cyclase.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

9.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

10.  L-3,4-dihydroxyphenylalanine-induced hypersensitivity simulating features of denervation.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

View more
  1 in total

1.  Purine involvement in morphine antinociception.

Authors:  P Mantegazza; R Tammiso; F Zambotti; L Zecca; N Zonta
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.